Local law firm recognized nationally by Newsweek as a leader in asbestos/mesothelioma litigation

Submitted press release

Lipsitz & Ponterio has announced that the firm has been recognized by Newsweek magazine as a prominent leader in the representation of mesothelioma victims. With more than 50 years of combined legal experience in New York, Lipsitz & Ponterio represents victims of mesothelioma and lung cancer caused by exposure to asbestos.

Each firm contacted for Newsweek's "20 Leaders in Asbestos Law" is in good standing with well-known law associations or has been recognized for excellence by respective local media outlets.

"We are very proud of the firm's work, and we are grateful to Newsweek for giving the firm this recognition," said Michael A. Ponterio, founding partner of Lipsitz & Ponterio. "It has been a privilege to represent families across New York state whose loved ones regrettably suffered debilitating and, in some cases, fatal asbestos diseases."

Lipsitz & Ponterio is led by its three partners: John N. Lipsitz, Ponterio and John P. Comerford. The firm has successfully represented thousands of plaintiffs across New York in lawsuits against the manufacturers and distributors of asbestos-containing products. Lipsitz & Ponterio's clients are located throughout the country and have histories of asbestos exposure at New York job sites, including Durez Plastics in North Tonawanda, Bethlehem Steel in Lackawanna, Rochester Gas & Electric and Kodak Park in Rochester. The firm also leads the way in proving liability for many different asbestos-containing products, ranging from joint compound to brake linings to household boiler equipment.

About Lipsitz & Ponterio

Lipsitz & Ponterio, LLC, established in 1995, concentrates its practice in the areas of asbestos disease and lead poisoning litigation, medical malpractice, product liability, personal injury and worker's compensation matters. The firm has achieved thousands of settlements and numerous verdicts on behalf of its clients who were harmed by toxic substances. For more information, visit Lipsitz & Ponterio's website at www.lipsitzponterio.com.